Lemerond Nicole 4
4 · InMed Pharmaceuticals Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Lemerond Nicole
Director
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-12-16+840→ 1,400 totalExercise: $1.78Exp: 2027-12-15→ Common shares (840 underlying)
Footnotes (2)
- [F1]The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner.
- [F2]On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.